Hct G.L.

Hct G.L., containing the thiazide diuretic hydrochlorothiazide, is an oral prescription medication marketed in the European Union. It belongs to the class of thiazide diuretics and is used to manage fluid balance and blood pressure. The product is supplied without a specified strength or dosage form in this description, and it is intended for use under medical supervision. Patients should follow the prescribing clinician's guidance regarding dosing and monitoring.

Hydrochlorothiazide in Hct G.L. is indicated for several conditions where reduction of excess fluid or control of blood pressure is required.

- Hypertension (high blood pressure) management, often as part of combination therapy. - Edema associated with congestive heart failure, liver cirrhosis, or renal disease. - Prevention of fluid retention in patients receiving corticosteroid therapy. - Adjunctive treatment for calcium‑containing kidney stones by reducing urinary calcium excretion. - Short‑term control of hypertension in patients who cannot tolerate other antihypertensive agents.

Like other thiazide diuretics, hydrochlorothiazide may cause a range of side effects, most of which are mild and reversible.

Common: - Increased urination and mild dehydration. - Low blood potassium (hypokalemia) leading to muscle cramps. - Elevated blood glucose levels, particularly in diabetic patients. - Dizziness or light‑headedness upon standing (orthostatic hypotension).

Serious: - Severe electrolyte disturbances such as hyponatremia or hyperuricemia. - Allergic reactions including rash, itching, or angio‑edema. - Acute kidney injury manifested by sudden decrease in urine output.

Before starting Hct G.L., clinicians should evaluate several factors to minimize risks and ensure safe use.

- Assess baseline kidney function and serum electrolytes, especially potassium and sodium. - Monitor blood pressure regularly to avoid excessive hypotension. - Use caution in patients with a history of gout, as thiazides can raise uric acid levels. - Evaluate for diabetes mellitus, since thiazides may impair glucose tolerance. - Avoid in individuals with known hypersensitivity to sulfonamide‑derived drugs. - Consider dose adjustment in elderly patients due to increased susceptibility to dehydration. - Review concomitant use of other diuretics or medications that affect electrolyte balance.

Hydrochlorothiazide can interact with a variety of medicines, altering its effectiveness or increasing the risk of adverse effects.

Avoid: - Concurrent use with lithium, which can raise lithium concentrations and cause toxicity. - Combination with non‑steroidal anti‑inflammatory drugs (NSAIDs) that may reduce diuretic efficacy and impair kidney function. - Simultaneous administration with other potent diuretics (e.g., loop diuretics) without medical supervision.

Use with caution: - ACE inhibitors, ARBs, or beta‑blockers, which may enhance the blood‑pressure‑lowering effect. - Antidiabetic agents, as thiazides can increase blood glucose levels. - Anticoagulants such as warfarin, where electrolyte shifts may affect INR stability. - Calcium‑channel blockers, which may increase the risk of edema.